Marinus Pharmaceuticals, Inc. revenue breakdown overview

Marinus Pharmaceuticals, Inc. revenue for the last year amounted to 30.99 M USD, the most of which — 30.99 M USD — came from its highest performing source at the moment, Therapeutics for Rare Seizures, the year earlier bringing 25.48 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Marinus Pharmaceuticals, Inc. 30.99 M USD, and the year before that — 25.48 M USD.